Radiopharm Theranostics Ltd

Radiopharm Theranostics Ltd.

Biotechnology • Healthcare • Carlton, VIC, United States • RDPTF (PNK)

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.

61 3 9824 5254 62 Lygon Street, Carlton, VIC 3053, Australia

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Favourable Signals For Radiopharm Theranostics: Numerous Insiders Acquired Stock - Yahoo Finance
Yahoo Finance • Dec 21
Why Is Radiopharm Theranostics Stock (RADX) Up Today? - TipRanks
TipRanks • Dec 15
Radiopharm Theranostics Surge: Buy or Sell? - timothysykes.com
timothysykes.com • Dec 15
RADX Stock Soars: Is It Time to Buy? - StocksToTrade
StocksToTrade • Dec 15
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Update - MarketBeat
MarketBeat • Dec 30

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Radiopharm Theranostics Ltd had layoffs?
No layoff events have been recorded for Radiopharm Theranostics Ltd in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Radiopharm Theranostics Ltd have?
Radiopharm Theranostics Ltd has approximately 14 employees.
What industry is Radiopharm Theranostics Ltd in?
Radiopharm Theranostics Ltd operates in the Biotechnology industry, within the Healthcare sector.
Is Radiopharm Theranostics Ltd a publicly traded company?
Yes, Radiopharm Theranostics Ltd is publicly traded under the ticker symbol RDPTF on the PNK. The company has a market capitalization of approximately $0.05 billion.
Where is Radiopharm Theranostics Ltd headquartered?
Radiopharm Theranostics Ltd is headquartered in Carlton, VIC, United States at 62 Lygon Street, Carlton, VIC 3053, Australia.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.